Chicago Equity Partners’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Chicago Equity Partners’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-115,194	Closed	-$2.75M	–	944
2019 Q4	$2.75M	Sell	115,194 -44,310	-28%	-$1.22M	0.16%	185
2019 Q3	$4.28M	Buy	+159,504	New	+$4.48M	0.2%	140
2018 Q1	–	Sell	-21,729	Closed	-$1.06M	–	840
2017 Q4	$1.06M	Sell	21,729 -18,110	-45%	-$916K	0.03%	495
2017 Q3	$2.15M	Buy	39,839 +34,194	+606%	+$2.01M	0.07%	355
2017 Q2	$317K	Buy	+5,645	New	+$226K	0.01%	690

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Chicago Equity Partners's PTLA Position: Q1 2020 in Review

Chicago Equity Partners sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 115,194 shares — an estimated $2.75M sold.

Chicago Equity Partners first reported a position in PTLA in Q2 2017 and held it in 5 quarters. The position peaked at $4.28M in Q3 2019. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

Chicago Equity Partners reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Chicago Equity Partners sold 115,194 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $2.75M.
Chicago Equity Partners first reported a position in Portola Pharmaceuticals, Inc. in Q2 2017 and held it in 5 quarters.
Chicago Equity Partners's Portola Pharmaceuticals, Inc. position peaked at $4.28M in Q3 2019.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.